Concourse Financial Group Securities, Inc. Ikena Oncology, Inc. Call Options Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IKNA
# of Institutions
38Shares Held
27.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$6.93 Million1.48% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$5.53 Million0.21% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$4.88 Million0.17% of portfolio
-
Deep Track Capital, LP Greenwich, CT2.52MShares$3.47 Million0.12% of portfolio
-
Omega Fund Management, LLC Boston, MA2.25MShares$3.1 Million6.49% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $50M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...